Gene Query: EVA1A

Dataset Description Geneva Score
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 36.42
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 35.83
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 25.48
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 25.48
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 22.93
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 19.32
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 17.8
STRIPAK directs PP2A activity to promote oncogenic transformation 17.5
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 17.48
TGF-β promotes genomic instability after loss of RUNX3 17.32
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 17.3
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 16.93
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 15.81
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 15.17
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 14.49
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 14.31
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 13.85
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 12.97
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 12.97
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 12.74
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 12.5
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 12.09
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 11.89
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 11.87
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 11.67
RNA-seq of shEZH2 cells 11.52
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 11.49
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 11.49
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 10.71
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 10.71
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.67
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 10.52
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 10.4
Chromatin-informed inference of transcriptional programs in gynecologic cancers 10.37
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 10.37
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 9.97
KLF6-dependent transcription in renal cancer cells 9.79
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.76
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 9.59
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 9.39
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.33
RNA-seq of human aneuploid cell lines with Trisomy 21 9.03
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 8.96
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 8.55
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 8.49
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 8.48
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 8.37
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 8.37
Identification of Sin3B regulated genes during quiescence 8.3
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 8.28
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 8.2
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 8.13
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 7.98
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 7.97
RNA-Sequencing of HepG2 cells treated with TGFBeta 7.91
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 7.89
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 7.89
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 7.74
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 7.64
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.61
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 7.57
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.56
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.36
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.36
ARID1A regulates condensin II distribution and chromosomal partition 7.35
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 7.35
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.2
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.11
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.11
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.1
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 7.02
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 6.86
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 6.71
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 6.67
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 6.67
Region-specific Innate Antiviral Responses of the Human Epididymis 6.63
Effect of Hotair overexpression in human breast cancer cell lines 6.59
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 6.53
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 6.53
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.4
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.39
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 6.36
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 6.36
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 6.36
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 6.36
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.33
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.32
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 6.31
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 6.3
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 6.29
High level DNA repair gene expression in human ES cells 6.27
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 6.27
Statins modulate endothelial transcriptional profile by inhibiting EZH2 6.25
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 6.16
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 6.15
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 6.13
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 6.11
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 6.1
Genome-wide chromatin analysis of Ewing sarcoma 6.1
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.08
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.08
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.06
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 5.86
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 5.86
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.83
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.83
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 5.78
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.73
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 5.72
Gene expression signatures of innate lymphoid cells from human blood 5.71
Real-time observation of light-controlled transcription in living cells 5.65
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 5.64
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 5.64
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.62
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.57
Analysis of transcriptional regulation by Myt1 and Myt1l 5.55
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.54
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.54
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.53
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 5.51
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 5.5
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 5.5
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.5
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.5
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 5.41
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.39
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 5.37
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.36
ARID1A and ARID1B loss in HCT116 and TOV21G cells 5.34
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 5.32
A sister of NANOG regulates genes expressed in pre-implantation human development 5.3
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.28
Transcriptome analysis of U87 cells upon LINC00152 knockdown 5.26
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.25
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 5.24
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 5.23
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 5.23
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.2
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 5.12
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 4.97
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.86
GATA3-mediated chromatin reprogramming in breast cancer cells 4.84
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.81
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 4.8
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.78
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 4.76
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 4.76
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 4.68
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 4.68
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 4.66
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.6
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.6
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.59
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.59
Transcriptomic analyssis following EHMT1/2 inhibition 4.56
RNA-sequencing of human liver tissue 4.52
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.52
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 4.5
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 4.44
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 4.38
Role of CD133 molecule in WNT response and renal repair 4.38
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 4.38
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.37
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 4.35
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 4.28
Effect of mitochondria deficiency on senescence-associated gene expression 4.27
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 4.25
Differential analysis of gene regulation at transcript resolution by RNA-Seq 4.25
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 4.23
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 4.21
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.2
p53 activity results in DNA replication fork processivity 4.18
RNA-seq of young and quiescent MRC-5 human fibroblasts 4.18
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 4.13
mRNA differential expression analysis in a human ex vivo model of chronic wounds 4.12
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 4.12
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 4.1
RNA-seq of cells with TET1 knockout 4.08
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.08
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 4.04
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 3.99
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 3.98
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.96
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.96
Gene expression profile difference among renal location in a stone former 3.95
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 3.94
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 3.93
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.92
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 3.9
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 3.84
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 3.77
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 3.76
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 3.72
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.7
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 3.69
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 3.68
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 3.67
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 3.66
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.64
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.64
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.63
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 3.62
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 3.62
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.53
RNAseq Study in CC-671 Treated Cal-51 Cells 3.51
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 3.49
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 3.49
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 3.49
Gene expression analysis of human liver progenitor-like cells in culture 3.46
Non-coding regions are the main source of tumor-specific antigens [human] 3.45
Non-coding regions are the main source of tumor-specific antigens 3.45
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 3.43
The human blood-nerve barrier transcriptome 3.43
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.43
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 3.42
Evaluating pre-clinical models for studying NASH driven HCC. 3.39
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 3.39
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 3.37
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 3.37
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.37
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 3.34
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 3.32
CHD1 regulates cell fate determination by activation of differentiation-induced genes 3.32
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 3.32
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.3
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.28
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.25
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.24
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 3.23
DJ-1 is dispensable for human stem cell homeostasis 3.22
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.19
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 3.19
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 3.19
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.19
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.18
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.18
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.18
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 3.16
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 3.16
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 3.15
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 3.15
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 3.14
IRF2 is a master regulator of human keratinocyte stem cell fate 3.14
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 3.12
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.1
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 3.09
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 3.09
Primary human trophoblast from term placenta 3.08
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 3.07
Transcriptome analysis of human lung epithelial cells 3.07
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 3.04
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 3.03
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.02
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 3.02
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 3.02
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 3.01
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 3.01
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 3.0
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.99
High-efficiency RNA-based reprogramming of human primary fibroblasts 2.98
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 2.97
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 2.97
The bromodomain protein BRD4 regulates splicing during heat shock 2.93
Expression profiling of converted and control dermal BJ fibroblasts 2.91
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 2.91
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 2.91
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 2.88
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.87
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.85
Disruption of the exocyst induces podocyte loss and dysfunction 2.83
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.83
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.82
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 2.82
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.81
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.81
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.81
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 2.81
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.8
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 2.79
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.75
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 2.73
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.73
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.73
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 2.72
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 2.72
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.72
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.72
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 2.7
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.7
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.69
Discovering human diabetes-risk gene function with genetics and physiological assays 2.68
Effect of from Human Umbilical Vein Endothelial Cells 2.67
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 2.67
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.67
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 2.66
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 2.66
RNA-seq analysis of control and Myc-induced U2OS cells 2.64
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 2.64
Single-nucleotide-resolution mapping of HBV promoters using CAGE 2.63
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.63
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.63
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.62
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.6
The effect of PPARG inhibition on human angiomyolipoma cells 2.58
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 2.58
Expression profiling of etoposide-induced senescent cells 2.58
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.57
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 2.56
Generation of trichogenic adipose-derived stem cells by expression of three factors 2.55
Neurofibroma 2.55
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 2.55
Redifferentiation of expanded human islet β cells by inhibition of ARX 2.55
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.54
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.54
CDK12 mediated transcriptional regulation in U2OS cells 2.51
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.5
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.5
Direct Isolation and Characterization of Human Nephron Progenitors. 2.47
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.47
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.47
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 2.47
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 2.47
Nucleoporin-mediated regulation of cell identity genes 2.45
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 2.43
Transcriptome analysis of kidney organoids 2.43
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 2.42
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 2.42
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.39
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.38
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.37
RNA-seq of MCF10A cells and CAF 2.35
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.32
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 2.32
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 2.32
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.31
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.29
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.25
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 2.22
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 2.16
Endothelial gene expression analysis 2.16
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  2.15
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.15
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.15
Characterization of human ILC2 subsets 2.15
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.13
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 2.09
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 2.09
Generation of KRAS signatures using immortalized isogenic lung cells. 2.05
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.04
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.95
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 1.91
Gene profiling of human adult and pediatric liver cancer cells 1.9
RNA-seq of cancer cell lines treated with T-025 1.88
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.87
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.87
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.86
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.84
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.77
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.75
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.74
Transcriptomic analysis of LSD1 1.72
1.7
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.68
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.68
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.68
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.68
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.68
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.66
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.66
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.65
Random mono-allelic expression in MECP2-mutated cells 1.61
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.61
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.6
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.59
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.56
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.53
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.53
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.52
Gene expression profiling of human and murine in vitro muscle differentiation 1.5
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.5
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.49
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 1.46
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 1.45
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 1.43
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 1.43
Gene expression of collecting duct carcinoma of the kidney 1.42
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.41
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.41
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.38
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 1.38
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 1.38
RNA-seq analysis upon ARID1B overexpression 1.3
Transciptomic profiling of human fetal lung samples 1.29
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.28
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 1.25
The cohesin complex prevents Myc-induced replication stress 1.2
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.2
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.19
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.18
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 1.17
RNA editing in nascent RNA affects pre-mRNA splicing 1.17
Gene expression of thyroid cancer cell lines 1.13
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.12
Differential gene expression in Jagged1 treated human dental pulp cells. 1.11
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.11
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.11
JAK dependent survival of ALK- ALCL 1.08
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.95
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.95
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.93
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.93
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.9
EGR1-controlled transcriptome of T HESCs 0.87
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.87
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.86
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.85
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.84
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.84
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.83
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 0.82
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 0.81
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.81
Alagille_Nodder 0.8
RNA Seq of Alagille liver biopsies 0.8
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.79
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.79
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.79
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.78
IMP3 regulated gene expression in breast cancer cells 0.77
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.76
Transcriptome analysis of virus infected tissues 0.74
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.73
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.7
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 0.68
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.68
Investigate A2M treatment on human prostate cancer xenograft in mice 0.67
Investigate A2M treatment on human prostate cancer and mouse liver 0.67
Hepatocyte maturation 0.65
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.65
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.61
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.61
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.6
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.6
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.6
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.59
Gene expression profile in breast cancer cells 0.59
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.59
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.56
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.56
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.56
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.56
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 0.53
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.51
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.51
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 0.45
miRNAs affected by antagomiR-17 treatment 0.44
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.44
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.43
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.43
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.42
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.39
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 0.39
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.39
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.38
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.35
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.32
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.32
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.31
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.29
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.26
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 0.23
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.23
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.21
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.21
SF3B1 Degron knockdown RNA-seq 0.21
Regulation of hypoxia-inducible factor activity by ZMYND8 0.21
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.2
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.19
Gene expression changes in human melanoma cell lines compared to primary melanocytes 0.19
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.19
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.17
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.16
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.15
Deep RNA sequencing of the human placental transcriptome 0.15
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.13
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.12
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.12
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.1
BMS-470539 on human synovial fibroblasts 0.1
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.1
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.07
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.05
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.04
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.02
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.01
hNSCs siRNA NOVA2 0.01
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 0.01
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation